Suppr超能文献

用体外细胞毒性方法替代体内急性经口毒性研究:机遇、局限与监管状况

Replacement of in vivo acute oral toxicity studies by in vitro cytotoxicity methods: opportunities, limits and regulatory status.

作者信息

Ukelis Ute, Kramer Peter-Jürgen, Olejniczak Klaus, Mueller Stefan O

机构信息

Global Regulatory Affairs, Merck Serono, Merck KGaA, 64271 Darmstadt, Germany.

出版信息

Regul Toxicol Pharmacol. 2008 Jun;51(1):108-18. doi: 10.1016/j.yrtph.2008.02.002. Epub 2008 Feb 21.

Abstract

The development of a new medicinal product is a long and costly process in particular due to the regulatory requirements for quality, safety and efficacy. There is a common interest to increase the efficiency of drug development and to provide new, better quality medicinal products much faster to the public. One possible way to economize time and costs, as well as to consider animal protection issues, is to introduce new alternative methods into non-clinical toxicity testing. Currently, animal tests are mandatory for the evaluation of acute toxicity of chemicals and new drugs. The replacement of the in vivo tests by alternative in vitro assays would offer the opportunity to screen and assess numerous compounds at the same time, to predict acute oral toxicity and thus accelerate drug development. Moreover, the substitution of in vivo tests by in vitro methods shows a proactive pursuit of ethical and animal welfare issues. Importantly, the implementation of in vitro assays for acute oral toxicity would require the establishment of common test guidelines across the EU, USA and Japan, i.e., the regions of ICH (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use). Presently, alternative in vitro tests are being investigated internationally. Yet, in order to achieve regulatory acceptance and implementation of in vitro assays, convincing results from validation studies are required. In this review, we discuss the current regulatory status of acute oral toxicity testing and point out achievements of alternative methods. We describe the application of in vitro tests, correlating in vitro with in vivo data. The use of in vitro data to predict in vivo acute oral toxicity is analyzed using the Registry of Cytotoxicity, an official independent database. We have then analyzed opportunities and drawbacks for future implementation of in vitro test methods, with particular focus on industrial use.

摘要

新药的研发是一个漫长且成本高昂的过程,特别是由于对质量、安全性和有效性的监管要求。提高药物研发效率并更快地向公众提供新的、质量更好的药品是共同的利益所在。节省时间和成本以及考虑动物保护问题的一种可能方法是在非临床毒性测试中引入新的替代方法。目前,动物试验是评估化学品和新药急性毒性的强制性要求。用替代的体外试验取代体内试验将提供同时筛选和评估大量化合物的机会,以预测急性口服毒性,从而加速药物研发。此外,用体外方法替代体内试验显示出对伦理和动物福利问题的积极追求。重要的是,实施急性口服毒性的体外试验需要在欧盟、美国和日本(即人用药品注册技术要求国际协调会议的地区)建立共同的测试指南。目前,替代体外试验正在国际上进行研究。然而,为了获得监管部门对体外试验的认可和实施,验证研究需要有令人信服的结果。在这篇综述中,我们讨论了急性口服毒性测试的当前监管状况,并指出替代方法的成果。我们描述了体外试验的应用,将体外数据与体内数据相关联。使用细胞毒性登记处(一个官方独立数据库)分析了利用体外数据预测体内急性口服毒性的情况。然后,我们分析了未来实施体外测试方法的机会和缺点,特别关注工业用途。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验